Product Code: TMRGL54720
The report provides revenue of the global non-invasive ventilators market for the period 2017-2031, considering 2021 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global non-invasive ventilators market from 2022 to 2031.
The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the non-invasive ventilators market.
The report delves into the competitive landscape of the global non-invasive ventilators market. Key players operating in the global non-invasive ventilators market have been identified and each one of these has been profiled, in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are attributes of players in the global non-invasive ventilators market profiled in this report.
Table of Contents
1. Preface
- 1.1. Market Definition and Scope
- 1.2. Market Segmentation
- 1.3. Key Research Objectives
- 1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary : Global Non-invasive Ventilators Market
4. Market Overview
- 4.1. Introduction
- 4.1.1. Product Type Definition
- 4.1.2. Industry Evolution / Developments
- 4.2. Overview
- 4.3. Market Dynamics
- 4.3.1. Drivers
- 4.3.2. Restraints
- 4.3.3. Opportunities
- 4.4. Global Non-invasive Ventilators Market Analysis and Forecasts, 2017 - 2031
- 4.4.1. Market Revenue Projections (US$ Mn)
5. Key Insights
- 5.1. Pricing Analysis
- 5.2. Key Industry Events (Merger& Acquisitions, and etc.)
- 5.3. Economic burden of COPD
- 5.4. COVID 19 Impact Analysis
6. Global Non-invasive Ventilators Market Analysis and Forecast, by Product Type
- 6.1. Introduction & Definition
- 6.2. Key Findings / Developments
- 6.3. Market Value Forecast, by Product Type, 2017 - 2031
- 6.3.1. Systems
- 6.3.1.1. Non-invasive PPV
- 6.3.1.2. High Flow Nasal Cannula O2 Delivery
- 6.3.1.3. Other Non-invasive
- 6.3.2. Consumables
- 6.3.2.1. Mask
- 6.3.2.2. Humidifiers
- 6.3.2.3. PEEP Valves
- 6.3.2.4. Others (tubes, connectors, and etc.)
- 6.4. Market Attractiveness, by Product Type
7. Global Non-invasive Ventilators Market Analysis and Forecast, by End-user
- 7.1. Introduction & Definition
- 7.2. Key Findings / Developments
- 7.3. Market Value Forecast, by End-user, 2017 - 2031
- 7.3.1. Critical Care
- 7.3.2. NICU Care
- 7.3.3. Transport (ambulance)
- 7.3.4. Home Care Settings
- 7.4. Market Attractiveness, by End-user
8. Global Non-invasive Ventilators Market Analysis and Forecast, by Application
- 8.1. Introduction & Definition
- 8.2. Key Findings / Developments
- 8.3. Market Value Forecast, by Application, 2017 - 2031
- 8.3.1. Chronic Obstructive Pulmonary Disease
- 8.3.2. Asthma
- 8.3.3. Respiratory Distress Syndrome
- 8.3.4. Pneumonia
- 8.3.5. Others
- 8.4. Market Attractiveness, by Application
9. Global Non-invasive Ventilators Market Analysis and Forecast, by Region
- 9.1. Key Findings
- 9.2. Market Value Forecast, by Region
- 9.2.1. North America
- 9.2.2. Europe
- 9.2.3. Asia Pacific
- 9.2.4. Latin America
- 9.2.5. Middle East & Africa
- 9.3. Market Attractiveness, by Country/Region
10. North America Non-invasive Ventilators Market Analysis and Forecast
- 10.1. Introduction
- 10.2. Market Value Forecast, by Product Type, 2017 - 2031
- 10.2.1. Systems
- 10.2.1.1. Non-invasive PPV
- 10.2.1.2. High Flow Nasal Cannula O2 Delivery
- 10.2.1.3. Other Non-invasive
- 10.2.2. Consumables
- 10.2.2.1. Mask
- 10.2.2.2. Humidifiers
- 10.2.2.3. PEEP Valves
- 10.2.2.4. Others (tubes, connectors, and etc.)
- 10.3. Market Value Forecast, by End-user, 2017 - 2031
- 10.3.1. Critical Care
- 10.3.2. NICU Care
- 10.3.3. Transport (ambulance)
- 10.3.4. Home Care Settings
- 10.4. Market Value Forecast, by Application, 2017 - 2031
- 10.4.1. Chronic Obstructive Pulmonary Disease
- 10.4.2. Asthma
- 10.4.3. Respiratory Distress Syndrome
- 10.4.4. Pneumonia
- 10.4.5. Others
- 10.5. Market Value Forecast, by Country, 2017 - 2031
- 10.5.1. U.S.
- 10.5.2. Canada
- 10.6. Market Attractiveness Analysis
- 10.6.1. By Product Type
- 10.6.2. By End-user
- 10.6.3. By Application
- 10.6.4. By Country
11. Europe Non-invasive Ventilators Market Analysis and Forecast
- 11.1. Introduction
- 11.2. Market Value Forecast, by Product Type, 2017 - 2031
- 11.2.1. Systems
- 11.2.1.1. Non-invasive PPV
- 11.2.1.2. High Flow Nasal Cannula O2 Delivery
- 11.2.1.3. Other Non-invasive
- 11.2.2. Consumables
- 11.2.2.1. Mask
- 11.2.2.2. Humidifiers
- 11.2.2.3. PEEP Valves
- 11.2.2.4. Others (tubes, connectors, and etc.)
- 11.3. Market Value Forecast, by End-user, 2017 - 2031
- 11.3.1. Critical Care
- 11.3.2. NICU Care
- 11.3.3. Transport (ambulance)
- 11.3.4. Home Care Settings
- 11.4. Market Value Forecast, by Application, 2017 - 2031
- 11.4.1. Chronic Obstructive Pulmonary Disease
- 11.4.2. Asthma
- 11.4.3. Respiratory Distress Syndrome
- 11.4.4. Pneumonia
- 11.4.5. Others
- 11.5. Market Value Forecast, by Country/Sub-region, 2017 - 2031
- 11.5.1. Germany
- 11.5.2. U.K.
- 11.5.3. France
- 11.5.4. Spain
- 11.5.5. Italy
- 11.5.6. Rest of Europe
- 11.6. Market Attractiveness Analysis
- 11.6.1. By Product Type
- 11.6.2. By End-user
- 11.6.3. By Application
- 11.6.4. By Country/Sub-region
12. Asia Pacific Non-invasive Ventilators Market Analysis and Forecast
- 12.1. Introduction
- 12.2. Market Value Forecast, by Product Type, 2017 - 2031
- 12.2.1. Systems
- 12.2.1.1. Non-invasive PPV
- 12.2.1.2. High Flow Nasal Cannula O2 Delivery
- 12.2.1.3. Other Non-invasive
- 12.2.2. Consumables
- 12.2.2.1. Mask
- 12.2.2.2. Humidifiers
- 12.2.2.3. PEEP Valves
- 12.2.2.4. Others (tubes, connectors, and etc.)
- 12.3. Market Value Forecast, by End-user, 2017 - 2031
- 12.3.1. Critical Care
- 12.3.2. NICU Care
- 12.3.3. Transport (ambulance)
- 12.3.4. Home Care Settings
- 12.4. Market Value Forecast, by Application, 2017 - 2031
- 12.4.1. Chronic Obstructive Pulmonary Disease
- 12.4.2. Asthma
- 12.4.3. Respiratory Distress Syndrome
- 12.4.4. Pneumonia
- 12.4.5. Others
- 12.5. Market Value Forecast, by Country/Sub-region, 2017 - 2031
- 12.5.1. China
- 12.5.2. Japan
- 12.5.3. India
- 12.5.4. Australia & New Zealand
- 12.5.5. Rest of Asia Pacific
- 12.6. Market Attractiveness Analysis
- 12.6.1. By Product Type
- 12.6.2. By End-user
- 12.6.3. By Application
- 12.6.4. By Country/Sub-region
13. Latin America Non-invasive Ventilators Market Analysis and Forecast
- 13.1. Introduction
- 13.2. Market Value Forecast, by Product Type, 2017 - 2031
- 13.2.1. Systems
- 13.2.1.1. Non-invasive PPV
- 13.2.1.2. High Flow Nasal Cannula O2 Delivery
- 13.2.1.3. Other Non-invasive
- 13.2.2. Consumables
- 13.2.2.1. Mask
- 13.2.2.2. Humidifiers
- 13.2.2.3. PEEP Valves
- 13.2.2.4. Others (tubes, connectors, and etc.)
- 13.3. Market Value Forecast, by End-user, 2017 - 2031
- 13.3.1. Critical Care
- 13.3.2. NICU Care
- 13.3.3. Transport (ambulance)
- 13.3.4. Home Care Settings
- 13.4. Market Value Forecast, by Application, 2017 - 2031
- 13.4.1. Chronic Obstructive Pulmonary Disease
- 13.4.2. Asthma
- 13.4.3. Respiratory Distress Syndrome
- 13.4.4. Pneumonia
- 13.4.5. Others
- 13.5. Market Value Forecast, by Country, 2017 - 2031
- 13.5.1. Brazil
- 13.5.2. Mexico
- 13.5.3. Rest of Latin America
- 13.6. Market Attractiveness Analysis
- 13.6.1. By Product Type
- 13.6.2. By End-user
- 13.6.3. By Application
- 13.6.4. By Country/Sub-region
14. Middle East & Africa Non-invasive Ventilators Market Analysis and Forecast
- 14.1. Introduction
- 14.2. Market Value Forecast, by Product Type, 2017 - 2031
- 14.2.1. Systems
- 14.2.1.1. Non-invasive PPV
- 14.2.1.2. High Flow Nasal Cannula O2 Delivery
- 14.2.1.3. Other Non-invasive
- 14.2.2. Consumables
- 14.2.2.1. Mask
- 14.2.2.2. Humidifiers
- 14.2.2.3. PEEP Valves
- 14.2.2.4. Others (tubes, connectors, and etc.)
- 14.3. Market Value Forecast, by End-user, 2017 - 2031
- 14.3.1. Critical Care
- 14.3.2. NICU Care
- 14.3.3. Transport (ambulance)
- 14.3.4. Home Care Settings
- 14.4. Market Value Forecast, by Application, 2017 - 2031
- 14.4.1. Chronic Obstructive Pulmonary Disease
- 14.4.2. Asthma
- 14.4.3. Respiratory Distress Syndrome
- 14.4.4. Pneumonia
- 14.4.5. Others
- 14.5. Market Value Forecast, by Country, 2017 - 2031
- 14.5.1. GCC Countries
- 14.5.2. South Africa
- 14.5.3. Rest of Middle East & Africa
- 14.6. Market Attractiveness Analysis
- 14.6.1. By Product Type
- 14.6.2. By End-user
- 14.6.3. By Application
- 14.6.4. By Country/Sub-region
15. Competition Landscape
- 15.1. Market Player - Competition Matrix (By Tier and Size of companies)
- 15.2. Market Share Analysis By Company (2021)
- 15.3. Company Profiles
- 15.3.1. Teleflex Incorporated
- 15.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
- 15.3.1.2. Financial Analysis
- 15.3.1.3. Growth Strategies
- 15.3.1.4. SWOT Analysis
- 15.3.2. Vyaire Medical
- 15.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
- 15.3.2.2. Financial Analysis
- 15.3.2.3. Growth Strategies
- 15.3.2.4. SWOT Analysis
- 15.3.3. Dragerwerk AG & Co. KGaA
- 15.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
- 15.3.3.2. Financial Analysis
- 15.3.3.3. Growth Strategies
- 15.3.3.4. SWOT Analysis
- 15.3.4. GE Healthcare
- 15.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
- 15.3.4.2. Financial Analysis
- 15.3.4.3. Growth Strategies
- 15.3.4.4. SWOT Analysis
- 15.3.5. Medtronic plc
- 15.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
- 15.3.5.2. Financial Analysis
- 15.3.5.3. Growth Strategies
- 15.3.5.4. SWOT Analysis
- 15.3.6. Koninklijke Philips N.V.
- 15.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
- 15.3.6.2. Financial Analysis
- 15.3.6.3. Growth Strategies
- 15.3.6.4. SWOT Analysis
- 15.3.7. Smiths Medical
- 15.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
- 15.3.7.2. Financial Analysis
- 15.3.7.3. Growth Strategies
- 15.3.7.4. SWOT Analysis
- 15.3.8. ResMed, Inc.
- 15.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
- 15.3.8.2. Financial Analysis
- 15.3.8.3. Growth Strategies
- 15.3.8.4. SWOT Analysis
- 15.3.9. O-Two Medical Technologies Inc.
- 15.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
- 15.3.9.2. Financial Analysis
- 15.3.9.3. Growth Strategies
- 15.3.9.4. SWOT Analysis
- 15.3.10. Dimar s.r.l.
- 15.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
- 15.3.10.2. Financial Analysis
- 15.3.10.3. Growth Strategies
- 15.3.10.4. SWOT Analysis
- 15.3.11. Intersurgical Ltd.
- 15.3.11.1. Company Overview (HQ, Business Segments, Employee Strength)
- 15.3.11.2. Financial Analysis
- 15.3.11.3. Growth Strategies
- 15.3.11.4. SWOT Analysis
- 15.3.12. HAROL S.r.l.
- 15.3.12.1. Company Overview (HQ, Business Segments, Employee Strength)
- 15.3.12.2. Financial Analysis
- 15.3.12.3. Growth Strategies
- 15.3.12.4. SWOT Analysis
- 15.3.13. Vygon SA
- 15.3.13.1. Company Overview (HQ, Business Segments, Employee Strength)
- 15.3.13.2. Financial Analysis
- 15.3.13.3. Growth Strategies
- 15.3.13.4. SWOT Analysis
- 15.3.14. Getinge AB
- 15.3.14.1. Company Overview (HQ, Business Segments, Employee Strength)
- 15.3.14.2. Financial Analysis
- 15.3.14.3. Growth Strategies
- 15.3.14.4. SWOT Analysis
- 15.3.15. Vapotherm, Inc.
- 15.3.15.1. Company Overview (HQ, Business Segments, Employee Strength)
- 15.3.15.2. Financial Analysis
- 15.3.15.3. Growth Strategies
- 15.3.15.4. SWOT Analysis
- 15.3.16. Fisher & Paykel Healthcare Limited
- 15.3.16.1. Company Overview (HQ, Business Segments, Employee Strength)
- 15.3.16.2. Financial Analysis
- 15.3.16.3. Growth Strategies
- 15.3.16.4. SWOT Analysis